High
13.110
Open
13.090
VWAP
13.09
Vol
19.38M
Mkt Cap
551.63M
Low
13.065
Amount
253.74M
EV/EBITDA(TTM)
--
Total Shares
82.95M
EV
1.17B
EV/OCF(TTM)
--
P/S(TTM)
4.26
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
71.38M
+14.51%
--
--
69.50M
+13.91%
--
--
69.62M
+13.98%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Paragon 28, Inc. (FNA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.15%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+0.15%
In Past 3 Month
5 Analyst Rating
-0.69% Downside
Wall Street analysts forecast FNA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FNA is 13.00 USD with a low forecast of 13.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
5 Hold
0 Sell
Hold
-0.69% Downside
Current: 13.090
Low
13.00
Averages
13.00
High
13.00
-0.69% Downside
Current: 13.090
Low
13.00
Averages
13.00
High
13.00
Stephens & Co.
Mason Carrico
Buy
to
Hold
Downgrades
$14 → $13
2025-01-30
Reason
Stephens & Co.
Mason Carrico
Price Target
$14 → $13
2025-01-30
Downgrades
Buy
to
Hold
Reason
Stephens downgraded Paragon 28 (FNA) to Equal Weight from Overweight with a $13 price target after Zimmer Biomet (ZBH) agreed to acquire the company for $13 in cash per share plus up $1 per share in a contingent value right.
William Blair
Brandon Vazquez
Buy
to
Hold
Downgrades
n/a
2025-01-29
Reason
William Blair
Brandon Vazquez
Price Target
n/a
2025-01-29
Downgrades
Buy
to
Hold
Reason
Needham
Mike Matson
Strong Buy
to
Hold
Downgrades
$13
2025-01-29
Reason
Needham
Mike Matson
Price Target
$13
2025-01-29
Downgrades
Strong Buy
to
Hold
Reason
Canaccord Genuity
Kyle Rose
Strong Buy
to
Hold
Downgrades
n/a
2025-01-29
Reason
Canaccord Genuity
Kyle Rose
Price Target
n/a
2025-01-29
Downgrades
Strong Buy
to
Hold
Reason
Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet (ZBH) agreed to acquire the company for $13 in cash per share plus up $1 per share in a contingent value right.
Needham
Mike Matson
Strong Buy
Reiterates
$13
2025-01-13
Reason
Needham
Mike Matson
Price Target
$13
2025-01-13
Reiterates
Strong Buy
Reason
Needham
Mike Matson
Strong Buy
Maintains
$11 → $13
2024-11-13
Reason
Needham
Mike Matson
Price Target
$11 → $13
2024-11-13
Maintains
Strong Buy
Reason
Needham analyst Mike Matson raised the firm's price target on Paragon 28 to $13 from $11 and keeps a Buy rating on the shares. The company's Q3 results demonstrated "significant progress" on profitability and cash flow, and it was also the first quarter since Paragon's IPO that it had positive EBITDA, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Paragon 28 Inc (FNA.N) is -28.02, compared to its 5-year average forward P/E of -39.32. For a more detailed relative valuation and DCF analysis to assess Paragon 28 Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-39.32
Current PE
-28.02
Overvalued PE
-17.18
Undervalued PE
-61.47
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.83
Current EV/EBITDA
142.82
Overvalued EV/EBITDA
714.29
Undervalued EV/EBITDA
-712.64
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
5.26
Current PS
3.72
Overvalued PS
7.46
Undervalued PS
3.07
Financials
Annual
Quarterly
FY2024Q4
YoY :
+18.47%
71.75M
Total Revenue
FY2024Q4
YoY :
-42.71%
-6.43M
Operating Profit
FY2024Q4
YoY :
-43.15%
-11.12M
Net Income after Tax
FY2024Q4
YoY :
-45.83%
-0.13
EPS - Diluted
FY2024Q4
YoY :
-71.14%
-6.23M
Free Cash Flow
FY2024Q4
YoY :
-2.13%
72.92
Gross Profit Margin - %
FY2024Q4
YoY :
-59.49%
-17.21
FCF Margin - %
FY2024Q4
YoY :
-52.01%
-15.50
Net Margin - %
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 1605.97% over the last month.
Sold
0-3
Months
31.5M
USD
4
3-6
Months
3.0M
USD
9
6-9
Months
1.4M
USD
5
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1102.69% over the last quarter.
Sold
0-3
Months
9.6M
Volume
1
3-6
Months
797.4K
Volume
2
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
425.8K
Volume
Months
6-9
1
2.3M
Volume
Months
0-12
3
5.9M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
8.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
1
8.0K
USD
Months
Insider
Insiders areSelling! The selling amount has increased 1605.97% over the last month.
Sold
0-3
Months
31.5M
USD
4
3-6
Months
3.0M
USD
9
6-9
Months
1.4M
USD
5
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
FNA News & Events
Events Timeline
2025-03-11 (ET)
2025-03-11
16:02:31
Paragon 28 announces expiration of HSR waiting period for pending acquisition
2025-01-28 (ET)
2025-01-28
17:02:36
Zimmer Biomet to acquire Paragon 28 for $13.00 per share in cash upfront
2025-01-14 (ET)
2025-01-14
11:00:49
Paragon 28 falls -9.5%
Sign Up For More Events
Sign Up For More Events
News
7.0
04-09PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, BRDG, FNA on Behalf of Shareholders
7.0
04-02Globenewswire$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action
7.0
04-01PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MHLD, TURN, FNA, PTMN on Behalf of Shareholders
Sign Up For More News
People Also Watch
BXC
Bluelinx Holdings Inc
71.320
USD
+2.19%
AVAH
Aveanna Healthcare Holdings Inc
5.770
USD
-3.83%
NNE
Nano Nuclear Energy Inc
26.860
USD
+3.03%
UTL
Unitil Corp
54.440
USD
+0.74%
BFS
Saul Centers Inc
34.390
USD
+2.69%
REAX
Real Brokerage Inc
4.330
USD
-0.92%
UAN
CVR Partners LP
82.270
USD
+1.27%
GRNT
Granite Ridge Resources Inc
5.540
USD
-0.54%
ANGI
Angi Inc
16.419
USD
+0.42%
PFC
Premier Financial Corp (OHIO)
28.040
USD
-0.11%
FAQ
What is Paragon 28 Inc (FNA) stock price today?
The current price of FNA is 13.09 USD — it has increased 0 % in the last trading day.
What is Paragon 28 Inc (FNA)'s business?
What is the price predicton of FNA Stock?
What is Paragon 28 Inc (FNA)'s revenue for the last quarter?
What is Paragon 28 Inc (FNA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Paragon 28 Inc (FNA)'s fundamentals?
How many employees does Paragon 28 Inc (FNA). have?